|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/18/22 Preaxia Health Care Payment … Inc 10-Q 8/31/22 31:1.6M Bollman Trisha M/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 352K
2: EX-31 Certification -- §302 - SOA'02 HTML 15K
3: EX-32 Exhibti 32 HTML 12K
9: R1 Cover HTML 62K
10: R2 Consolidated Balance Sheets (Unaudited) HTML 93K
11: R3 Consolidated Balance Sheets (Unaudited) HTML 20K
(Parenthetical)
12: R4 Consolidated Statements of Operations and HTML 46K
Comprehensive Loss (Unaudited)
13: R5 Consolidated Statements of Changes in HTML 31K
Stockholder's Deficit (Unaudited)
14: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 56K
15: R7 Organization and Description of Business HTML 17K
16: R8 Summary of Significant Accounting Policies HTML 49K
17: R9 Recent Accounting Pronouncements HTML 24K
18: R10 Related Party Transactions HTML 27K
19: R11 Stockholders? Deficit HTML 20K
20: R12 Contingencies and Commitments HTML 15K
21: R13 Subsequent Events HTML 14K
22: R14 Summary of Significant Accounting Policies HTML 80K
(Policies)
23: R15 Organization and Description of Business (Details HTML 18K
Narrative)
24: R16 Summary of Significant Accounting Policies HTML 59K
(Details Narrative)
25: R17 Related Party Transactions (Details Narrative) HTML 46K
26: R18 Stockholders? Deficit (Details Narrative) HTML 20K
29: XML IDEA XML File -- Filing Summary XML 47K
27: XML XBRL Instance -- paxh8312022_htm XML 250K
28: EXCEL IDEA Workbook of Financial Reports XLSX 46K
5: EX-101.CAL XBRL Calculations -- paxh-20220831_cal XML 62K
6: EX-101.DEF XBRL Definitions -- paxh-20220831_def XML 105K
7: EX-101.LAB XBRL Labels -- paxh-20220831_lab XML 332K
8: EX-101.PRE XBRL Presentations -- paxh-20220831_pre XML 251K
4: EX-101.SCH XBRL Schema -- paxh-20220831 XSD 47K
30: JSON XBRL Instance as JSON Data -- MetaLinks 159± 222K
31: ZIP XBRL Zipped Folder -- 0001262463-22-000138-xbrl Zip 93K
EXHIBIT 31.1
RULE 13a-14(a)/15d-14(a) CERTIFICATION
I, Tom Zapatinas, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarter ended August 31, 2022 of PreAxia Health Care Payment Systems Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles,
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ Tom Zapatinas | |
| Tom Zapatinas, Chief Executive Officer and Chief Financial Officer | |
| (Principal Executive Officer and Principal Financial Officer) |
C:
| C: 1 |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 10/18/22 | |||
| Filed on: | 10/17/22 | NT 10-Q | ||
| For Period end: | 8/31/22 | NT 10-Q | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/21/11 Preaxia Health Care Payment … Inc 10-K 5/31/11 7:490K Newsfile Corp./FA 11/14/08 Preaxia Health Care Payment … Inc DEF 14C 9/30/08 1:84K Int’l Secs Group Inc. 5/19/08 Preaxia Health Care Payment … Inc 8-K:1,9 4/22/08 2:198K Int’l Secs Group Inc. 3/16/06 Preaxia Health Care Payment … Inc SB-2 8:673K Lawler & Associates/FA |